SCHEMBL3406318

SCHEMBL3406318

CN(CCCN1CCC(c2cccs2)(N(C)C)CC1)C(=O)CCc1c[nH]c2ccccc12

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.51
MAPT P10636 1/20 0.51
RAB9A P51151 1/20 0.51
NPC1 O15118 1/20 0.51
TACR2 P21452 4/20 0.49
CDK4 P11802 1/20 0.48
MC4R P32245 2/20 0.46
MC5R P33032 2/20 0.46
MC3R P41968 2/20 0.46
PKM P14618 2/20 0.45
GAA P10253 1/20 0.45
KMT2A Q03164 1/20 0.45
OPRL1 P41146 2/20 0.44
HTR1A P08908 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
ALDH1A1 P00352 1/20 0.44
LMNA P02545 1/20 0.44
OPRM1 P35372 1/20 0.42
GLA P06280 1/20 0.41
ACHE P22303 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4092770 0.88 NPC1 (0.56) SMN1; SMN2NPC1TACR2CDK4MC4R
SCHEMBL3410673 0.84 TACR2 (0.49) TACR2CDK4OPRL1ALDH1A1OPRM1
SCHEMBL3408609 0.84 HSD17B10 (0.42) SMN1; SMN2GAAKMT2AOPRL1NPSR1
SCHEMBL3406134 0.84 OPRL1 (0.55) MAPTPKMGAAKMT2AOPRL1
SCHEMBL3401667 0.84 OPRM1 (0.41) SMN1; SMN2MAPTRAB9ANPC1TACR2
SCHEMBL3407998 0.83 OPRM1 (0.40) SMN1; SMN2MAPTRAB9ANPC1TACR2
SCHEMBL3405562 0.82 CDK4 (0.57) SMN1; SMN2MAPTNPC1TACR2CDK4
SCHEMBL3408808 0.82 NPSR1 (0.42) TACR2OPRL1HTR1ANPSR1OPRM1
SCHEMBL3407011 0.79 GAA (0.45) SMN1; SMN2MAPTRAB9ACDK4MC5R
SCHEMBL206505 0.78 HPGD (0.53) SMN1; SMN2MAPTRAB9ANPC1CDK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9206156-B2 Substituted indole derivatives Grünenthal GmbH (DE) 2015-12-08 US claimed
EP-2254883-B1 SUBSTITUTED INDOLE DERIVATIVES GRUENENTHAL GMBH (DE) 2014-11-26 EP claimed
US-20130116283-A1 Substituted indole derivatives Grünenthal GmbH (DE) 2013-05-09 US claimed
EP-2254883-A1 SUBSTITUTED INDOLE DERIVATIVES Grünenthal GmbH (DE) 2010-12-01 EP claimed
WO-2009103552-A1 SUBSTITUTED INDOLE DERIVATIVES Grünenthal GmbH (DE) 2009-08-27 WO claimed
US-20090215828-A1 Substituted indole derivatives GRUNENTHAL GMBH (DE) 2009-08-27 US claimed
US-9206156-B2 Substituted indole derivatives Grünenthal GmbH (DE) 2015-12-08 US disclosed
US-9206156-B2 Substituted indole derivatives Grünenthal GmbH (DE) 2015-12-08 US disclosed
EP-2254883-B1 SUBSTITUTED INDOLE DERIVATIVES GRUENENTHAL GMBH (DE) 2014-11-26 EP disclosed
EP-2254883-B1 SUBSTITUTED INDOLE DERIVATIVES GRUENENTHAL GMBH (DE) 2014-11-26 EP disclosed
US-20130116283-A1 Substituted indole derivatives Grünenthal GmbH (DE) 2013-05-09 US disclosed
US-20130116283-A1 Substituted indole derivatives Grünenthal GmbH (DE) 2013-05-09 US disclosed
EP-2254883-A1 SUBSTITUTED INDOLE DERIVATIVES Grünenthal GmbH (DE) 2010-12-01 EP disclosed
WO-2009103552-A1 SUBSTITUTED INDOLE DERIVATIVES Grünenthal GmbH (DE) 2009-08-27 WO disclosed
US-20090215828-A1 Substituted indole derivatives GRUNENTHAL GMBH (DE) 2009-08-27 US disclosed
US-20090215828-A1 Substituted indole derivatives GRUNENTHAL GMBH (DE) 2009-08-27 US disclosed
US-20090215828-A1 Substituted indole derivatives GRUNENTHAL GMBH (DE) 2009-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215828-A1 Substituted indole derivatives IDO1, IDO2, TPH1 SMN1; SMN2 1803/4885MAPT 514/4885RAB9A 2580/4885
US-20130116283-A1 Substituted indole derivatives IDO1, IDO2, TPH1 SMN1; SMN2 1803/4885MAPT 514/4885RAB9A 2580/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.